Project description:OvCaRe stands for Ovarian Cancer Research. OvCaRe formed in late 2000 when a group of Vancouver-based physicians and scientists joined with the common vision of enhancing ovarian cancer research in British Columbia and the explicit goal of improving outcomes for ovariant cancer patients. OvCaRe researchers are a multidisciplicary team, spanning basic to clinical science to allow for a true bench-to-bedside approach. OvCaRe was developed as a collaboration between the BC Cancer Agency, the Vancouver Coastal Health Research Insititute, and Hospital Foundation and BC Cancer Foundation

| EGAO00000000013 | EGA

British Columbia Cancer Agency

Project description:Organisation EGAO00000000169

| EGAO00000000169 | EGA

British Columbia Cancer Agency (BCCA), Genome Sciences Centre

Project description:The mandate of the Genome Sciences Centre at BCCA is to advance knowledge about cancer and other diseases, to improve human health through disease prevention, diagnosis and therapeutic approaches, and to realize the social and economical benefits of genomics and informatics research

| EGAO00000000002 | EGA

British Columbia Cancer Agency Branch

Project description:Organisation EGAO00000000145

| EGAO00000000145 | EGA

British Columbia Cancer Agency (BCCA), Department of Molecular Oncology

Project description:The Department of Molecular Oncology at BCCA in Vancouver, BC, Canada aims to characterise the molecular changes that occur as tumours develop

| EGAO00000000014 | EGA

When access is an issue: exploring barriers to predictive testing for Huntington disease in British Columbia, Canada.

Project description:Predictive testing (PT) for Huntington disease (HD) requires several in-person appointments. This requirement may be a barrier to testing so that at risk individuals do not realize the potential benefits of PT. To understand the obstacles to PT in terms of the accessibility of services, as well as exploring mechanisms by which this issue may be addressed, we conducted an interview study of individuals at risk for HD throughout British Columbia, Canada. Results reveal that the accessibility of PT can be a barrier for two major reasons: distance and the inflexibility of the testing process. Distance is a structural barrier, and relates to the time and travel required to access PT, the financial and other opportunity costs associated with taking time away from work and family to attend appointments and the stress of navigating urban centers. The inflexibility of the testing process barrier relates to the emotional and psychological accessibility of PT. The results of the interview study reveal that there are access barriers to PT that deter individuals from receiving the support, information and counseling they require. What makes accessibility of PT services important is not just that it may result in differences in quality of life and care, but because these differences may be addressed with creative and adaptable solutions in the delivery of genetic services. The study findings underscore the need for us to rethink and personalize the way we deliver such services to improve access issues to prevent inequities in the health care system.

| S-EPMC3548262 | biostudies-other

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data